GRAIL (GRAL) Common Stock : $0.0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GRAIL Common Stock?

GRAIL's quarterly common stock increased from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil) and increased from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

GRAIL's annual common stock stayed the same from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then increased from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil).

GRAIL Common Stock Historical Data

The historical data trend for GRAIL's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Common Stock Chart

GRAIL Annual Data

Trend

Dec18

Dec19

Dec22

Dec23

Dec24

Common Stock

0.13

0.14

0.03

GRAIL Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial								-	0.03	0.03	0.03	0.03

GRAIL Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

GRAIL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

NL0:Germany

Address

1525 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.grail.com

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.